Source: Annual Congress 2008 - Basic science in asthma and COPD II
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Orozco-Levi, A. Sanchez-Font, C. Coronell, A. Ramirez-Sarmiento, J. Gea, V. Curull (Barcelona, Spain). Is soluble MICA facilitating tumor immune evasion in patients with COPD?. Eur Respir J 2008; 32: Suppl. 52, 1984

Member's Comments

No comment yet.

Related content which might interest you: Signs of MICA as an innate immune molecule potentially involved in vascular remodelling in patients with pulmonary hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Immunotherapy improves inflammatory cytokines, humoral immunity and cellular immunity in septic patients Source: Annual Congress 2010 - Pulmonary infections and sepsis Year: 2010 Human rhinovirus impairs macrophage innate immune responses to bacteria via the interferon pathway in COPD Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease Year: 2018 From ineffective tumor immune response to immunomodulation in lung cancer Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies? Year: 2017 Soluble ADAM33 augments the pulmonary innate immune response promoting susceptibility to allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 miRNAs and the regulation of the lung innate immune response Source: Annual Congress 2009 - miRNAs in inflammation and disease Year: 2009 Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity Year: 2020 Investigation the role of pentraxin-3 in the innate immune system in patients with COPD Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Determinants of lung cancer evolution: immune escape and inflammation Source: International Congress 2018 – Scientific Year in Review Year: 2018 Do antimicrobial peptides shape the adaptive immune response? Source: Annual Congress 2005 - Interaction between innate and adaptive immunity in lung disease Year: 2005 The innate immune function of airway epithelial cells in inflammatory lung disease Source: Eur Respir J 2015; 45: 1150-1162 Year: 2015 Suppression of pulmonary innate host defense in smokers Source: Annual Congress 2007 - The best of airway epithelial cells Year: 2007 The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 The role of innate immune cells in inflammation Source: International Congress 2015 – Resolving inflammation Year: 2015 Oral presentation: Targeting of microRNAs can restore innate anti-viral response in asthma Source: Lung Science Conference 2014 - Lung Inflammation and Immunity Year: 2014 The immuneresponse against bacterial antigens is generated in vivo by a mechanical bacterial lysate through a cross-talk between innate and adaptive immunity Source: Eur Respir J 2003; 22: Suppl. 45, 338s Year: 2003 LSC - 2019 - Azithromycin modulates viral-induced asthma exacerbation by targeting the innate immune response Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes Year: 2019 How do antigen presenting cells see pathogens and cells? Source: Annual Congress 2006 - Targeting innate immunity in respiratory diseases Year: 2006